Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359920120310040214
Korean Journal of Nephrology
2012 Volume.31 No. 4 p.214 ~ p.218
Risk factors for mortality in patients with acute kidney injury and hypotension treated with continuous veno-venous hemodiafiltration
Oh In-Myung

Lee Jang-Han
Yoo Kyoung-Hwa
Park Ji-Eun
Oh Dong-Hyun
Kim Mi-Jung
Ha Seung-Hea
Lee Gi-Jong
Kim Jung-Hee
Jung Yoon-Chul
Abstract
Background:Continuous veno-venous hemodiafiltration (CVVHDF) is a preferred treatment modality in hemodynamically unstable acute kidney injury (AKI) patients, because it has advantages over intermittent dialysis in terms of hemodynamic stability. However, this patient group still shows a significantly high mortality rate. To aid in the management of these high-risk patients, we evaluated the risk factors for mortality in CVVHDF-treated hypotensive AKI patients. Methods:We studied 67 patients with AKI and hypotension who were treated with CVVHDF from February 2008 to August 2010. We reviewed patient characteristics and laboratory parameters to evaluate the risk factors for 90-day mortality. Results:Of the 67 enrolled patients (male:female¨ù42:25; mean age¨ù69714 years), 18 (27%) survived until 90 days after the initiation of CVVHDF. There was no significant difference in survival rates according to the etiology of AKI [hypovolemic shock 2/10 (20%), cardiogenic shock 4/20 (20%), septic shock 12/37 (32%)]. Univariate analysis did show significant differences between survivors and non-survivors in the frequency of ventilator use (44% vs. 76%, respectively; P¨ù0.02), APACHE II score (2977 vs. 3477, respectively; P¨ù0.01), SOFA score (1174 vs. 1374, respectively; P¨ù0.03), blood pH (7.370.1 vs. 7.270.1, respectively; P¨ù0.03), and rate of urine output o500mL for 12hours (50% vs. 80%, respectively; P¨ù0.03). A multivariate Cox proportional hazards model showed that a urine outputo500mL for 12hours was the only significant risk factor for 90-day mortality following CVVHDF treatment (odds ratio¨ù2.1, confidence interval¨ù1.01?4.4, P¨ù0.048). Conclusion:A urine outputo500mL for 12hours before the initiation of CVVHDF is an independent risk factor for 90-day mortality in hypotensive AKI patients treated with CVVHDF.
KEYWORD
Acute kidneyinjury, Hypotension, Mortality, Renal replacementtherapy
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø